Status:
COMPLETED
Prevalence of Rheumatic Heart Disease Among Pregnant Women in Kenya
Lead Sponsor:
Moi University
Collaborating Sponsors:
Moi Teaching and Referral Hospital
Mount Sinai Hospital, Canada
Conditions:
Cardiac Disease
Pregnancy Related
Eligibility:
FEMALE
18-45 years
Brief Summary
There is currently no routine screening for cardiac disease for pregnant women in areas of high prevalence. This study will aim to determine the point prevalence of cardiac disease in women presenting...
Detailed Description
Rheumatic heart disease (RHD) in pregnancy can be associated with severe maternal and neonatal morbidity and mortality. Early identification of these women and referral to specialized, multi-disciplin...
Eligibility Criteria
Inclusion
- pregnant women at any gestational age
- capable to give informed consent
Exclusion
- medically unstable: any condition or complication resulting from or independent of pregnancy that necessitates urgent care or that precludes full and informed consent process
Key Trial Info
Start Date :
January 31 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 12 2018
Estimated Enrollment :
612 Patients enrolled
Trial Details
Trial ID
NCT03411993
Start Date
January 31 2018
End Date
March 12 2018
Last Update
July 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moi Teaching and Referral Hospital
Eldoret, Kenya, 30100